Safety of Parkinson ' s Drug Nuplazid (Pimavanserin) Being Reviewed by FDA
The safety of the Parkinson ' s disease drug Nuplazid is being reviewed by the U.S. Food and Drug Administration.
The drug has been cited as a " suspect " medication in hundreds of deaths reported by health care providers, CNN reported.
Nuplazid,...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news